


Share Your Opinion
Anonymously Rate Your Experience & Make Work BetterShare Your Opinion
Anonymously Rate Your Experience & Make Work BetterAimmune Therapeutics employees are 86% more likely to recommend Aimmune Therapeutics as a great place to work
| 86% | Promoters |
|---|---|
| 14% | Passives |
| 0% | Detractors |
Working at Aimmune Therapeutics is rated highly by 8 employees, across various culture dimensions. Aimmune Therapeutics employees are most satisfied about CEO Rating, Compensation, and Environment categories, putting Aimmune Therapeutics’s culture in the Top 5% compared to similar sized companies on Comparably and in the Top 5% compared to other companies in San Francisco. See below in detail how working at Aimmune Therapeutics was rated by employees.
Overall Company Culture at Aimmune Therapeutics is rated A+
Last updated months ago
Aimmune Therapeutics ranks in the Top 5% of other companies on Comparably with 1-10 Employees for Overall Company Culture Score
Share Your Opinion
Anonymously Rate Your Experience & Make Work BetterOut of 2 Aimmune Therapeutics employee reviews, 100% were positive.
| Positive Reviews | 100% |
|---|---|
| Constructive Feedback | 0% |
What do you like best about the leadership team?Transparency and realness of the CCO
What is the best part about your compensation package?The Stocks and base pay
Aimmune is the second initial public offering of stock this week from the Bay Area
Our mission is to improve the lives of people with food allergies. We are developing desensitization treatments to help protect people with food allergies by potentially reducing the risk of allergic reactions, making accidental exposures to allergens less dangerous. We aim to address food allergies by providing a treatment option that goes beyond the current recommendations of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our work is grounded in our founding from within the food allergy community.
| Headquarter | 8000 Marina Boulevard, Suite 300 Brisbane, CA United States of America |
|---|---|
| Website | www.aimmune.com/ |
| Founding Date | 2011 |
| Tel | (650) 614-5220 |
| Company Status | Public |
| Stock | AIMT |
Aimmune Therapeutics competitors include Novo Nordisk and Biogen. Aimmune Therapeutics ranks 1st in Overall Culture Score on Comparably vs its competitors. See below how Aimmune Therapeutics compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.

8 employees at Aimmune Therapeutics have reviewed Aimmune Therapeutics across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.
Overall, the 8 Aimmune Therapeutics employees give their leadership a grade of A+, or Top 5% of similar size companies on Comparably. This includes specific ratings of their executive team, CEO, and manager.
Employees at Aimmune Therapeutics are extremely happy with their total compensation at Aimmune Therapeutics, which includes a combination of pay, stock and equity, and benefits.
Overall, employees at Aimmune Therapeutics are extremely happy with their team. 8 Participants grade the quality of their coworkers an A. The majority believe the meetings at Aimmune Therapeutics are effective, and the majority look forward to interacting with their coworkers.
The majority of employees at Aimmune Therapeutics believe the environment at Aimmune Therapeutics is positive. Most Participants believe the pace of work at Aimmune Therapeutics is comfortably fast. About 100% of the employees at Aimmune Therapeutics work 8 hours or less.
Overall, the employees at Aimmune Therapeutics are extremely happy, based on their aggregated ratings of future outlook, customer perception, and their excitement going to work.

The prevailing opinion from Comparably users in San Francisco about their company is that it was very prepared on their first day. San Francisco employees concluded that their overall onboarding experience was positive. 78% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
Employees’ understanding of Aimmune Therapeutics' KPIs and OKRs is essential for its success. Out of 1 Aimmune Therapeutics employees who’ve answered, “Are your company’s goals clear and are you invested in them?” 1 have said yes.
Aimmune Therapeutics’s CEO Dr. Jayson Dallas started in this role in 2018. Dr.’s approval rate is in the Top 5% of all CEOs of similar-sized companies on Comparably, and in the Top 5% compared to the CEOs of all other companies in San Francisco. Compared to Aimmune Therapeutics’s competitors, Dr. Jayson Dallas ranks right above Biogen CEO Michel Vounatsos. Under Jayson Dallas’s leadership, Aimmune Therapeutics employee respondents are most happy about their Compensation and the company’s Environment. Meetings and Team are two areas, according to respondents, where Aimmune Therapeutics could stand to see real improvement.
The Aimmune Therapeutics Executive Team is rated an “A+” and led by CEO Dr. Jayson Dallas, Senior Vice President of Global Regulatory Affairs and Quality Assurance William D. Turner, and CFO Eric Bjerkholt
Dr. Jayson Dallas CEO / President
Dr. Jayson Dallas serves as the CEO / President of Aimmune Therapeutics.
William D. Turner Senior Vice President of Global Regulatory Affairs and Quality Assurance
Mr. William D. Turner has been Senior Vice President of Global Regulatory Affairs and Quality Assurance at Aimmune... read more
Eric Bjerkholt CFO
Eric Bjerkholt serves as the CFO for Aimmune Therapeutics. Eric started at Aimmune Therapeutics in April of 2017. Eric... read more
William Turner SVP Technical Operations and Regulatory Science
William Turner serves as the SVP Technical Operations and Regulatory Science for Aimmune Therapeutics. William started... read more
Rezi Zawadzki Senior Director, Head of Biometrics
Rezi Zawadzki serves as the Senior Director, Head of Biometrics for Aimmune Therapeutics. Rezi started at Aimmune... read more
Christophe Degois Executive Director Business Development and Alliance Management
Christophe Degois serves as the Executive Director Business Development and Alliance Management for Aimmune... read more
Kristin Bennett Senior Director, Marketing
Kristin Bennett serves as the Senior Director, Marketing for Aimmune Therapeutics. Kristin started at Aimmune... read more
Brett Haumann Non Executive Director
Brett Haumann serves as the Non Executive Director for Aimmune Therapeutics. Brett started at Aimmune Therapeutics in... read more
Roberta Allen Executive Director & Head of Regulatory Science Communications
Roberta Allen serves as the Executive Director & Head of Regulatory Science Communications for Aimmune Therapeutics.... read more
The Diversity score provides insights into how diverse employees feel and rate their work experience at Aimmune Therapeutics across various culture dimensions.
Aimmune Therapeutics' PTO and Vacation policy typically gives 15-20 days off a year. Aimmune Therapeutics' benefits and PTO Package averages to represent a $1000 -$1500 cash value per month.

No Recent Jobs found for Aimmune Therapeutics on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably
In 2019, Aimmune Therapeutics applied for 3 H1B visas. Of the work permits applied for, 100% were approved.
H1B Applications Outcome
This data was calculated using publicly sourced data from OFLC Performance Data

Candidates By Department
Customer Support | 100% |
|---|
Candidates By Location
Leesville | 100% |
|---|
What is Aimmune Therapeutics address?
Aimmune Therapeutics location is at 8000 Marina Boulevard, Suite 300
Who is the CEO of Aimmune Therapeutics?
Aimmune Therapeutics CEO is Dr. Jayson Dallas, their score by employees is 85
What is Aimmune Therapeutics eNPS?
The eNPS for Aimmune Therapeutics is 86
Who are Aimmune Therapeutics competitors?
Aimmune Therapeutics main competitors are Novo Nordisk, Biogen
Who is Aimmune Therapeutics leadership?
William D. Turner, Eric Bjerkholt & William Turner are part of Aimmune Therapeutics leadership, Dr. Jayson Dallas is the CEO